Mankind Pharma and Innovent Biologics partner to license and commercialise Sintilimab EP News Bureau Dec 26, 2024 Sintilimab, marketed as TYVY (sintilimab injection) in China, is a high-quality PD-1 immunoglobulin G4 monoclonal antibody…
Miltenyi Biotec and Translational Health Science Institute collaborate to strengthen R&D in… EP News Bureau Jul 16, 2024 The collaboration aim to address the growing need for innovative treatments in the fight against cancer by developing innovative…
Lymphoma drug, pralatrexate outperforms remdesivir against COVID-19: Study IANS Jan 2, 2021 However, this chemotherapy drug can prompt significant side effects so immediate use for COVID-19 patients is not guaranteed, said…
